October 24, 20203 min read, 510 words
Published: October 24, 2020 | 3 min read, 510 words
By , , (Reuters) - AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.Slideshow The news signaled progress agai...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.